Diabetes-Related Quality Measure Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical TrialsByRobert A. Bailey, MD,Ujjwala Vijapurkar, PhD,Gary E. Meininger, MD,Marcia F. T. Rupnow, PhD,Lawrence Blonde, MDDecember 16th 2014
Participating Faculty: Diabetes-Related Quality Measure Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical TrialsByRobert A. Bailey, MD,Ujjwala Vijapurkar, PhD,Gary E. Meininger, MD,Marcia F.T. Rupnow, PhD,Lawrence Blonde, MDDecember 15th 2014
Attainment of Diabetes-Related Quality Measures With Canagliflozin Versus SitagliptinByRobert A. Bailey, MD,C. V. Damaraju, PhD,Silas C. Martin, MS,Gary E. Meininger, MD,Marcia F. T. Rupnow, PhD,Lawrence Blonde, MDJanuary 25th 2014
Quality Measure Attainment in Patients With Type 2 Diabetes MellitusByMarie-Hélène Lafeuille, MA,Amanda M. Grittner, MA,Jonathan Gravel, MSc,Robert A. Bailey, MD,Silas Martin, MS,Lawrence Garber, MD,Mei Sheng Duh, MPH, ScD,Patrick Lefebvre, MAJanuary 25th 2014
Quality Measure Attainment in Patients With Type 2 Diabetes Mellitus